{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T00:00:10Z","timestamp":1790380810592,"version":"4.1.0"},"reference-count":42,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T00:00:00Z","timestamp":1779408000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["li.uscap.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Laboratory Investigation"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.labinv.2026.106138","type":"journal-article","created":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T15:34:10Z","timestamp":1779464050000},"page":"106138","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Preanalytical Determinants of Patient Eligibility for Immune Checkpoint Inhibitors Revealed by Quantitative Programmed Cell Death Ligand-1 (PD-L1) Analysis"],"prefix":"10.1016","volume":"106","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7826-002X","authenticated-orcid":false,"given":"Alessandro","family":"Gambella","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Mastracci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Trambaiolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Guastini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Paudice","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Pigozzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Bozzano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Angerilli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Caputo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Parente","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Vanoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Fassan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Grillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.labinv.2026.106138_bib1","doi-asserted-by":"crossref","first-page":"248","DOI":"10.32074\/1591-951X-158","article-title":"Current prognostic and predictive biomarkers for gastrointestinal tumors in clinical practice","volume":"112","author":"Fassan","year":"2020","journal-title":"Pathologica"},{"key":"10.1016\/j.labinv.2026.106138_bib2","doi-asserted-by":"crossref","first-page":"352","DOI":"10.32074\/1591-951X-803","article-title":"PD-L1 evaluation in the gastrointestinal tract: from biological rationale to its clinical application","volume":"114","author":"Mastracci","year":"2022","journal-title":"Pathologica"},{"key":"10.1016\/j.labinv.2026.106138_bib3","doi-asserted-by":"crossref","first-page":"57","DOI":"10.32074\/1591-951X-836","article-title":"A practical approach for PD-L1 evaluation in gastroesophageal cancer","volume":"115","author":"Angerilli","year":"2023","journal-title":"Pathologica"},{"key":"10.1016\/j.labinv.2026.106138_bib4","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1080\/14737159.2023.2288267","article-title":"A charming molecular profile in the wrong tissue: the pathologist in the era of molecular diagnostics in the gastrointestinal tract","volume":"23","author":"Parente","year":"2023","journal-title":"Expert Rev Mol Diagn"},{"key":"10.1016\/j.labinv.2026.106138_bib5","doi-asserted-by":"crossref","first-page":"529","DOI":"10.32074\/1591-951X-1759","article-title":"The clinical impact of precise assessment of predictive biomarkers in gastroesophageal cancer: focus on the PD-L1 combined positive score (CPS) and tumor area positivity (TAP) systems","volume":"117","author":"Gambella","year":"2025","journal-title":"Pathologica"},{"key":"10.1016\/j.labinv.2026.106138_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.esmoop.2025.105846","article-title":"Critical insights on real-life PD-L1 histopathological workflow and assessment in esophageal, esophagogastric junction, and gastric carcinoma in Italy","volume":"10","author":"Gambella","year":"2025","journal-title":"ESMO Open"},{"key":"10.1016\/j.labinv.2026.106138_bib7","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1016\/S0140-6736(23)02033-0","article-title":"Pembrolizumab plus trastuzumab and chemotherapy for HER2-positive gastric or gastro-oesophageal junction adenocarcinoma: interim analyses from the phase 3 KEYNOTE-811 randomised placebo-controlled trial","volume":"402","author":"Janjigian","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.labinv.2026.106138_bib8","first-page":"574","article-title":"NCCN Guidelines updates: new immunotherapy strategies for improving outcomes in non-small cell lung cancer","volume":"7","author":"Gubens","year":"2019","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1016\/j.labinv.2026.106138_bib9","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1200\/JCO.2020.38.15_suppl.1000","article-title":"KEYNOTE-355: randomized, double-blind, phase III study of pembrolizumab + chemotherapy versus placebo + chemotherapy for previously untreated locally recurrent inoperable or metastatic triple-negative breast cancer","volume":"38","author":"Cortes","year":"2020","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.labinv.2026.106138_bib10","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1200\/JCO.18.01265","article-title":"Efficacy and safety of pembrolizumab in previously treated advanced cervical cancer: results from the phase II KEYNOTE-158 study","volume":"37","author":"Chung","year":"2019","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.labinv.2026.106138_bib11","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.annonc.2024.11.006","article-title":"Cutaneous melanoma: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up","volume":"36","author":"Amaral","year":"2025","journal-title":"Ann Oncol"},{"key":"10.1016\/j.labinv.2026.106138_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.modpat.2023.100220","article-title":"Impact of decalcification, cold ischemia, and deglycosylation on performance of programmed cell death ligand-1 antibodies with different binding epitopes: comparison of 7 clones","volume":"36","author":"Lawson","year":"2023","journal-title":"Mod Pathol"},{"key":"10.1016\/j.labinv.2026.106138_bib13","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s00428-019-02653-2","article-title":"PD-L1 expression in gastric cancer determined by digital image analyses: pitfalls and correlation with pathologist interpretation","volume":"476","author":"Kim","year":"2020","journal-title":"Virchows Arch"},{"key":"10.1016\/j.labinv.2026.106138_bib14","doi-asserted-by":"crossref","unstructured":"Badve SS, Kumar GL, Lang T, et al. AI based PD-L1 CPS quantifier software to identify more patients for checkpoint therapy in gastric cancer at pathologist-level interobserver concordance. 2024;42:2633. doi:10.1200\/JCO.2024.42.16_suppl.2633.","DOI":"10.1200\/JCO.2024.42.16_suppl.2633"},{"key":"10.1016\/j.labinv.2026.106138_bib15","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s00418-015-1316-4","article-title":"Factors affecting immunoreactivity in long-term storage of formalin-fixed paraffin-embedded tissue sections","volume":"144","author":"Grillo","year":"2015","journal-title":"Histochem Cell Biol"},{"key":"10.1016\/j.labinv.2026.106138_bib16","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1097\/PAI.0000000000000847","article-title":"The immunohistochemical expression of programmed death ligand 1 (PD-L1) is affected by sample overfixation","volume":"29","author":"Barber\u00e0","year":"2021","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"10.1016\/j.labinv.2026.106138_bib17","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1056\/NEJMoa2201445","article-title":"PD-1 blockade in mismatch repair-deficient, locally advanced rectal cancer","volume":"386","author":"Cercek","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.labinv.2026.106138_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.annonc.2022.08.016","article-title":"LBA7 neoadjuvant immune checkpoint inhibition in locally advanced MMR-deficient colon cancer: the NICHE-2 study","volume":"33","author":"Chalabi","year":"2022","journal-title":"Ann Oncol"},{"key":"10.1016\/j.labinv.2026.106138_bib19","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1038\/s41591-020-0805-8","article-title":"Neoadjuvant immunotherapy leads to pathological responses in MMR-proficient and MMR-deficient early-stage colon cancers","volume":"26","author":"Chalabi","year":"2020","journal-title":"Nat Med"},{"key":"10.1016\/j.labinv.2026.106138_bib20","doi-asserted-by":"crossref","first-page":"3153","DOI":"10.3390\/cancers17193153","article-title":"Immunotherapy-induced complete response in dMMR rectal cancer-a surgical dilemma?","volume":"17","author":"Loufopoulos","year":"2025","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.labinv.2026.106138_bib21","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1056\/NEJMoa2503701","article-title":"Perioperative durvalumab in gastric and gastroesophageal junction cancer","volume":"393","author":"Janjigian","year":"2025","journal-title":"N Engl J Med"},{"key":"10.1016\/j.labinv.2026.106138_bib22","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.dld.2025.12.005","article-title":"Number\/quality of endoscopic biopsy samples in gastrointestinal cancers for biomarker testing: all that glitters is not gold","volume":"58","author":"Grillo","year":"2026","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.labinv.2026.106138_bib23","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s00418-017-1558-4","article-title":"Section detachment in immunohistochemistry: causes, troubleshooting, and problem-solving","volume":"148","author":"Gambella","year":"2017","journal-title":"Histochem Cell Biol"},{"key":"10.1016\/j.labinv.2026.106138_bib24","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1007\/s00418-018-1765-7","article-title":"Coping with formalin banning in pathology: under vacuum long-term tissue storage with no added formalin","volume":"151","author":"Mastracci","year":"2019","journal-title":"Histochem Cell Biol"},{"key":"10.1016\/j.labinv.2026.106138_bib25","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1007\/s00418-017-1596-y","article-title":"Quality control in diagnostic immunohistochemistry: integrated on-slide positive controls","volume":"148","author":"Bragoni","year":"2017","journal-title":"Histochem Cell Biol"},{"key":"10.1016\/j.labinv.2026.106138_bib26","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1007\/s00418-024-02326-5","article-title":"Be bold, start cold! cold formalin fixation of colorectal cancer specimens granted superior DNA and RNA quality for downstream molecular analysis","volume":"162","author":"Nano","year":"2024","journal-title":"Histochem Cell Biol"},{"key":"10.1016\/j.labinv.2026.106138_bib27","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-49215-9","article-title":"The expression of PD-L1 in salivary gland carcinomas","volume":"9","author":"Vital","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.labinv.2026.106138_bib28","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.dld.2008.02.027","article-title":"The impact of biopsy number and site on the accuracy of intestinal metaplasia detection in the stomach A morphometric study based on virtual biopsies","volume":"40","author":"Mastracci","year":"2008","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.labinv.2026.106138_bib29","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-17204-5","article-title":"QuPath: open source software for digital pathology image analysis","volume":"7","author":"Bankhead","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.labinv.2026.106138_bib30","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1097\/PAI.0000000000001153","article-title":"Impact of prolonged ischemia on the immunohistochemical expression of programmed death ligand 1 (PD-L1)","volume":"31","author":"Barber\u00e0","year":"2023","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"10.1016\/j.labinv.2026.106138_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.modpat.2023.100159","article-title":"Tissue age affects antigenicity and scoring for the 22C3 immunohistochemistry companion diagnostic test","volume":"36","author":"Fernandez","year":"2023","journal-title":"Mod Pathol"},{"key":"10.1016\/j.labinv.2026.106138_bib32","doi-asserted-by":"crossref","first-page":"3138","DOI":"10.3390\/cancers14133138","article-title":"Comprehensive comparison of 22C3 and SP263 PD-L1 expression in non-small-cell lung cancer using routine clinical and conditioned archives","volume":"14","author":"Kim","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.labinv.2026.106138_bib33","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1016\/j.jtho.2019.08.2503","article-title":"Impact of specimen characteristics on PD-L1 testing in non-small cell lung cancer: validation of the IASLC PD-L1 testing recommendations","volume":"14","author":"Gagn\u00e9","year":"2019","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.labinv.2026.106138_bib34","doi-asserted-by":"crossref","first-page":"4297","DOI":"10.1097\/JS9.0000000000000064","article-title":"Patterns and prognostic values of programmed cell death-ligand 1 expression and CD8 + T-cell infiltration in small cell carcinoma of the esophagus: a retrospective analysis of 34 years of National Cancer Center data in China","volume":"110","author":"Zhang","year":"2024","journal-title":"Int J Surg"},{"key":"10.1016\/j.labinv.2026.106138_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2022.154042","article-title":"PD-L1 expression in head and neck cancer tissue specimens decreases with time","volume":"237","author":"Karpathiou","year":"2022","journal-title":"Pathol Res Pract"},{"key":"10.1016\/j.labinv.2026.106138_bib36","doi-asserted-by":"crossref","DOI":"10.1002\/cam4.70262","article-title":"Temporal effect on PD-L1 detection and novel insights into its clinical implications in non-small cell lung cancer","volume":"13","author":"Pathak","year":"2024","journal-title":"Cancer Med"},{"key":"10.1016\/j.labinv.2026.106138_bib37","doi-asserted-by":"crossref","first-page":"3103","DOI":"10.3390\/cancers17193103","article-title":"Decline of PD-L1 immunoreactivity with storage duration in formalin-fixed paraffin-embedded breast cancer specimens: implications for diagnostic accuracy and immunotherapy eligibility in triple-negative breast cancer","volume":"17","author":"Yanagihara","year":"2025","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.labinv.2026.106138_bib38","article-title":"Discordance in PD-L1 scores on repeat testing of non-small cell lung carcinomas","volume":"27","author":"Naso","year":"2021","journal-title":"Cancer Treat Res Commun"},{"key":"10.1016\/j.labinv.2026.106138_bib39","first-page":"3400","article-title":"The daily practice reality of PD-L1 (CD274) evaluation in non-small cell lung cancer: a retrospective study","volume":"19","author":"Verocq","year":"2020","journal-title":"Oncol Lett"},{"key":"10.1016\/j.labinv.2026.106138_bib40","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s004290100210","article-title":"Morphology and immunology of the human palatine tonsil","volume":"204","author":"Nave","year":"2001","journal-title":"Anat Embryol (Berl)"},{"key":"10.1016\/j.labinv.2026.106138_bib41","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.immuni.2024.01.006","article-title":"An atlas of cells in the human tonsil","volume":"57","author":"Massoni-Badosa","year":"2024","journal-title":"Immunity"},{"key":"10.1016\/j.labinv.2026.106138_bib42","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1016\/j.jtho.2016.08.146","article-title":"A harmonization study for the use of 22C3 PD-L1 immunohistochemical staining on Ventana\u2019s platform","volume":"11","author":"Neuman","year":"2016","journal-title":"J Thorac Oncol"}],"container-title":["Laboratory Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0023683726000681?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0023683726000681?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T23:14:46Z","timestamp":1790378086000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0023683726000681"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":42,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S0023683726000681"],"URL":"https:\/\/doi.org\/10.1016\/j.labinv.2026.106138","relation":{},"ISSN":["0023-6837"],"issn-type":[{"value":"0023-6837","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Preanalytical Determinants of Patient Eligibility for Immune Checkpoint Inhibitors Revealed by Quantitative Programmed Cell Death Ligand-1 (PD-L1) Analysis","name":"articletitle","label":"Article Title"},{"value":"Laboratory Investigation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.labinv.2026.106138","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 THE AUTHORS. Published by Elsevier Inc. on behalf of the United States & Canadian Academy of Pathology.","name":"copyright","label":"Copyright"}],"article-number":"106138"}}